What You Should Know:
- Sheba Medical Center, Israel’s largest hospital, and ARC Innovation, the innovation arm of Sheba, has announced a strategic partnership with Paradigm Health to establish a global network for clinical research.
- This collaboration aims to revolutionize the way clinical trials are conducted, making them more accessible, efficient, and patient-centered.
Leveraging AI to Optimize Clinical Trials
The partnership will utilize Paradigm's AI-driven
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery
What You Should Know:
- Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.
- The startegic partnership leverages Genesis' cutting-edge AI platform, GEMS, to accelerate drug discovery and development.
A Powerful Collaboration
Genesis Therapeutics' GEMS platform utilizes advanced AI techniques to generate and
Read More
American Cancer Society and Yosemite Award $6M in Research Grants to Innovate Cancer Scientists
What You Should Know:
The American Cancer Society (ACS) and Yosemite, an oncology-focused venture capital firm, announced the selection of research grants through their Yosemite-ACS Award totaling more than $6 million.These inaugural grants will go to scientists from institutions across the country and are poised to make an impact in immuno-oncology as well as the use of Artificial Intelligence (AI) in cancer prevention, detection, treatment, and healthcare
Read More
Kahun Launches AI Agent for Pharma-Focused Knowledge Sharing
What You Should Know:
- Kahun, a pioneer in medical knowledge structuring, has introduced a new AI Agent specifically designed for the pharmaceutical industry.
- The AI Agent aims to bridge the gap between medical knowledge and patient context, providing professionals with reliable and accessible drug-related information.
Addressing the Challenges of Pharma-Related Information
The rapid pace of drug development and research has made it increasingly difficult for
Read More
Abbott Launches OTC Continuous Glucose Monitor, Lingo
What You Should Know:
- Abbott, a global healthcare company, has announced the U.S. availability of Lingo, a continuous glucose monitoring (CGM) system designed for individuals who want to improve their overall health and wellness.
- Lingo is the first CGM available without a prescription designed for individuals who want to improve their overall health and wellness, regardless of whether they have diabetes.
A Powerful Tool for Health Management
Lingo combines a biosensor
Read More
Genetic Leap, Eli Lilly Partner to Advance RNA Genetic Medicine
What You Should Know:
- Genetic Leap, a pioneering AI-native techbio company, has entered into a strategic research collaboration with Eli Lilly and Company.
- The partnership aims to develop innovative genetic medicine therapeutics using Genetic Leap's cutting-edge RNA-targeted AI platform.
Leveraging AI to Revolutionize RNA Drug Discovery
RNA genetic medicine holds immense promise for addressing a wide range of diseases. By targeting RNA, scientists can potentially
Read More
A Roadmap For Improving Diversity in Cancer Research and Advancing Therapeutic Development
Last month was Cancer Research Awareness Month, which is a great time to celebrate recent findings that the number of adults enrolled in oncology clinical trials has increased – nearly twice as high as past estimates – while also reflecting on the fact that we still have much work to do in overall and proportional clinical trial enrollment. Highlighting the work that still needs to be done, a recent analysis revealed that individuals who participated in new drug trials were not representative of
Read More
FCS Partners with Paradigm to Expand Clinical Trial Access
What You Should Know:
- Florida Cancer Specialists & Research Institute (FCS), a leading provider of comprehensive cancer care, has announced a new partnership with Paradigm Health, a technology platform specializing in clinical trial management.
- The collaboration aims to expand patient access to innovative treatments through more efficient clinical trial recruitment and execution.
A Strategic Partnership for Enhanced Clinical Trial Access
FCS has experienced steady
Read More
Pfizer Launches PfizerForAll: Connecting Patients to Care, Medications & Vaccinations
What You Should Know:
- Pharmaceutical giant Pfizer launches PfizerForAll, a user-friendly platform designed to simplify access to healthcare and wellness management for Americans.
- PfizerForAll addresses a common frustration: the difficulty of navigating the US healthcare system.
- A recent poll by the American Academy of Physician Associates found that 65% of Americans find managing their health overwhelming, and 73% feel the system fails to meet their needs.
Read More
OMNY Health Launches GLP-1 Data Network to Advance Research
What You Should Know:
- OMNY Health, a healthcare ecosystem specializing in data partnerships, today announced the launch of its GLP-1 data network.
- The GLP-1 data network aims to democratize access to healthcare data and empower researchers, clinicians, and life sciences companies to gain valuable insights into GLP-1 therapies.
Addressing Data Gaps in GLP-1 Research
Despite the growing use of GLP-1 agonists, there remains a significant lack of comprehensive data on
Read More
